```html

Zoster‑Induced Facial Paralysis (Ramsay Hunt Syndrome)

What is Zoster‑induced facial paralysis?

Zoster‑induced facial paralysis, also known as Ramsay Hunt syndrome type 1 or Herpes Zoster Oticus, occurs when the varicella‑zoster virus (VZV) that causes chicken‑pox reactivates in the facial nerve (cranial nerve VII) or the adjacent vestibulocochlear nerve (cranial nerve VIII). The virus damages the nerve sheath, leading to sudden weakness or total loss of facial movement on the affected side, often accompanied by a painful rash in the ear canal or on the tongue.

The condition is distinct from the more common idiopathic Bell’s palsy, although both present with facial weakness. Recognizing the viral origin is crucial because antiviral therapy can improve outcomes if started early.

Common Causes

While the primary trigger is reactivation of VZV, several factors increase the risk of developing zoster‑induced facial paralysis:

• Previous chicken‑pox infection – the virus remains dormant in sensory ganglia.
• Advanced age – immune surveillance declines after age 50.
• Immunosuppression – HIV/AIDS, organ transplant, chemotherapy, or chronic steroids.
• Stress or severe illness – can precipitate viral reactivation.
• Diabetes mellitus – impairs cellular immunity.
• Trauma to the ear or face – may create a local environment that favors viral spread.
• Hearing loss or ear surgery – disrupts the facial nerve’s protective bony canal.
• Autoimmune disorders – e.g., systemic lupus erythematosus, which alter immune response.
• Vaccination status – lack of shingles vaccine (Shingrix) in eligible adults.
• Concurrent ear infections (otitis media/externa) – may mask early viral signs.

Associated Symptoms

Facial weakness is rarely isolated. Typical accompanying features include:

• Ear pain (otalgia) – often severe and throbbing.
• Vesicular rash – blisters appear on the external ear, ear canal, or the oral cavity (hard palate, tongue).
• Hearing loss – can be sudden or progressive, usually sensorineural.
• Tinnitus or ringing in the ear.
• Vertigo or disequilibrium – due to involvement of the vestibular portion of cranial nerve VIII.
• Dry mouth or altered taste – the chorda tympani branch carries taste fibers from the anterior two‑thirds of the tongue.
• Difficulty closing the eye – leading to dryness, redness, or corneal abrasions.
• Drooling or difficulty swallowing – if the facial nerve’s motor function to buccal muscles is impaired.
• Facial twitching or spasms – after the acute phase, synkinesis may develop.

When to See a Doctor

Prompt evaluation is essential. Contact a healthcare professional if you notice:

• Sudden onset of facial weakness on one side, especially with ear pain.
• A rash or blisters developing around the ear, mouth, or on the face.
• Hearing changes, ringing, or balance problems.
• Inability to close the eye, causing eye irritation.
• Fever, severe headache, or neck stiffness (possible meningitis).
• Symptoms lasting longer than 48 hours without improvement.

Early treatment (ideally within 72 hours) improves the chance of full recovery and reduces the risk of permanent facial weakness.

Diagnosis

Diagnosis combines a focused history, physical examination, and targeted investigations.

Clinical Evaluation

• History – recent shingles, immunosuppression, onset timing, associated ear pain, and rash description.
• Physical exam – assessment of facial nerve branches (forehead, eye, cheek, mouth), inspection for vesicles, audiometric testing, and vestibular/cranial‑nerve exam.
• House‑Brackmann grading system – grades facial paralysis from I (normal) to VI (complete). Used to track recovery.

Laboratory & Imaging Tests

• Polymerase chain reaction (PCR) of vesicle fluid or a swab from the ear canal to confirm VZV DNA.
• Serology – VZV IgM/IgG may support diagnosis but is less specific.
• MRI with contrast – evaluates inflammation of the facial nerve and rules out tumors or stroke.
• CT scan of temporal bone – useful if bone involvement or otitis media is suspected.
• Audiogram – quantifies hearing loss and helps differentiate sensorineural from conductive components.

Treatment Options

Management is multimodal, aiming to halt viral replication, reduce inflammation, protect the eye, and support nerve recovery.

Antiviral Therapy

• Acyclovir 800 mg five times daily, valacyclovir 1 g three times daily, or famciclovir 500 mg three times daily for 7‑10 days.
• Start within 72 hours of symptom onset for maximum benefit (reduces facial paralysis severity by up to 40%).

Corticosteroids

• Prednisone 60 mg daily (or 1 mg/kg) for 5 days then taper over 5‑10 days.
• Combined with antivirals, steroids improve facial nerve recovery and shorten the time to improvement.

Eye Care

• Artificial tears every 2‑4 hours.
• Eye ointment (e.g., erythromycin ophthalmic ointment) at night.
• Moisture chamber or tape the eyelid closed during sleep if lagophthalmos persists.

Pain Management

• Acetaminophen or ibuprofen for mild‑moderate pain.
• Gabapentin or pregabalin for neuropathic pain if needed.

Physical Therapy & Facial Rehabilitation

• Gentle facial exercises to prevent contractures.
• Biofeedback or electrical stimulation under therapist guidance.
• Massage and moist heat to improve circulation.

Adjunctive Measures

• Vaccination: Shingrix (recombinant zoster vaccine) for adults ≥ 50 years or immunocompromised adults ≥ 18 years – reduces risk of reactivation.
• Control of comorbidities – optimal glucose control in diabetes, prompt management of HIV viral load, etc.

Prevention Tips

Because the underlying virus is dormant, complete prevention is impossible, but risk can be lowered:

• Receive the shingles vaccine (Shingrix) – >90 % efficacy in preventing zoster and post‑herpetic complications.
• Maintain a healthy immune system: balanced diet, regular exercise, adequate sleep, and stress‑reduction techniques.
• Manage chronic diseases (diabetes, hypertension) according to physician recommendations.
• Avoid smoking and limit alcohol, both of which impair cellular immunity.
• Practice good ear hygiene; avoid inserting objects into the ear canal that could cause micro‑trauma.
• If you have a known VZV reactivation (shingles) on any part of the body, seek early antiviral treatment to prevent spread to the facial nerve.
• Stay up‑to‑date with routine vaccinations (influenza, COVID‑19) that can prevent secondary infections that may trigger viral reactivation.

Emergency Warning Signs

Key Take‑aways

Zoster‑induced facial paralysis is a medical emergency that requires swift antiviral and anti‑inflammatory treatment to maximize recovery. Recognizing the characteristic painful ear rash, hearing changes, and facial weakness—and seeking care within the first 72 hours—greatly improves outcomes. Preventive vaccination and good immune health remain the best long‑term strategies.

References:

• Mayo Clinic. “Ramsay Hunt syndrome.” Updated 2023.
• CDC. “Shingles (Herpes Zoster) Vaccine.” Accessed May 2026.
• National Institute on Deafness and Other Communication Disorders (NIDCD). “Facial nerve disorders.” 2022.
• Cleveland Clinic. “Ramsay Hunt Syndrome – Treatment & Recovery.” 2024.
• Jain, S. et al. “Antiviral plus corticosteroid therapy for Ramsay Hunt syndrome: a systematic review.” *JAMA Otolaryngology–Head & Neck Surgery*, 2021.

```